DYN - Dyne Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.40
DETAILS
HIGH:
$60.00
LOW:
$23.00
MEDIAN:
$38.50
CONSENSUS:
$37.40
UPSIDE:
115.31%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 506 | 1,366 | 842 | 1,466 | 3 | 3 | 1,585 | 2,323 | 2,468 | 3,549 | 3,103 |
| Cost of Revenue | 2.0 | 2.2 | 2.5 | 0 | 0 | 0.7 | 0.3 | 0.0 | 2,932 | 2,281 | 2,028 | 1,145 | 1,145 | 268 | 963 | 1,181 | 1,194 | 1,853 | 2,013 |
| Gross Profit | (2.0) | (2.2) | (2.5) | 0 | 0 | (0.7) | (0.3) | (0.0) | (2,426) | (915) | (1,186) | 321 | (1,142) | (265) | 622 | 1,142 | 1,274 | 1,696 | 1,090 |
| Operating Expenses | |||||||||||||||||||
| R&D Expenses | 398.3 | 281.4 | 210.8 | 142.8 | 121.3 | 45.2 | 11.0 | 4.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 69.9 | 62.5 | 31.4 | 28.2 | 28.7 | 12.7 | 2.8 | 0.5 | 189 | 161 | 128 | (97) | 97 | (22) | 135 | 163 | (159) | (157) | (203) |
| Other Expenses | 0 | (2.2) | (2.5) | 0 | 0 | 0 | 0 | (0.0) | 0 | 0 | 0 | (211) | 0 | (59) | 0 | 0 | (360) | (337) | 0 |
| Operating Expenses | 466.1 | 341.6 | 239.7 | 171.0 | 150.0 | 57.9 | 13.8 | 4.8 | 189 | 161 | 128 | (308) | 97 | (81) | 135 | 163 | (519) | (494) | (203) |
| Operating Income | |||||||||||||||||||
| Operating Income | (468.2) | (343.9) | (242.2) | (171.0) | (150.0) | (58.6) | (13.8) | (4.8) | (412) | (640) | 64 | (318) | (318) | 714 | (236) | (11) | (834) | 709 | 605 |
| Interest Expense | 6.2 | 0 | 0 | 2.9 | 0 | 0.4 | 0 | 0.0 | 616 | 625 | 546 | 67 | 97 | 0 | 357 | 363 | 415 | 427 | 384 |
| Interest Income | 29.9 | 26.9 | 7.6 | 2.9 | 0.7 | 0.1 | 0.3 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||||||||||||||
| EBITDA | (438.0) | (315.2) | (233.5) | (169.3) | (148.9) | (58.3) | (14.6) | (4.8) | 949 | 106 | 736 | 292 | 150 | 113 | (1,574) | 734 | (173) | 902 | 830 |
| EBIT | (440.0) | (317.4) | (235.9) | (171.0) | (150.0) | (59.0) | (14.9) | (4.8) | 78 | (664) | 119 | (201) | (320) | 0 | (1,920) | 128 | (940) | 673 | 651 |
| Income Before Tax | (446.2) | (317.4) | (235.9) | (168.1) | (149.3) | (59.4) | (14.9) | (4.8) | (538) | (1,289) | (427) | (268) | (417) | 87 | (2,277) | (235) | (1,355) | 246 | 267 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | (0.7) | 0 | (0.0) | (610) | (45) | (474) | 117 | (58) | 0 | (632) | 197 | 315 | (75) | (151) |
| Net Income | (446.2) | (317.4) | (235.9) | (168.1) | (149.3) | (58.7) | (13.5) | (4.8) | 76 | (1,240) | 50 | (67) | (356) | 87 | (1,645) | (234) | (1,262) | 174 | 264 |
| Per Share Data | |||||||||||||||||||
| EPS (Basic) | -3.47 | -3.37 | -3.95 | -3.23 | -2.93 | -1.24 | -0.30 | -0.47 | 0.47 | -9.61 | 0.40 | -0.53 | -3.56 | 0.87 | -13.48 | -1.95 | -1.25 | 0.20 | 0.25 |
| EPS (Diluted) | -3.47 | -3.37 | -3.95 | -3.23 | -2.93 | -1.24 | -0.30 | -0.47 | 0.47 | -9.61 | 0.40 | -0.53 | -3.56 | 0.87 | -13.48 | -1.93 | -1.25 | 0.20 | 0.25 |
| Shares Outstanding | 128.4 | 94.1 | 59.7 | 52.0 | 50.9 | 47.3 | 45.4 | 10.3 | 162 | 129 | 125 | 126 | 100 | 100 | 122 | 120 | 1,009.6 | 870 | 1,042.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||
| Cash & Cash Equivalents | 893.4 | 435.4 | 121.6 | 172.1 | 200.8 | 300.9 | 14.6 | 8.1 | 365 | 1,776 | 471 | 693 |
| Short-Term Investments | 217.2 | 206.8 | 1.5 | 83.9 | 175.7 | 44.5 | 0 | 0 | 32 | 130 | 78 | 87 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 513 | 386 | 212 | 340 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 445 | 445 | 141 | 184 |
| Other Current Assets | 16.0 | 17.0 | 6.3 | 9.6 | 0 | 0 | 0 | 0 | 169 | 250 | 1,136 | 1,499 |
| Total Current Assets | 1,126.6 | 659.3 | 129.4 | 265.6 | 382.4 | 349.1 | 14.8 | 8.2 | 1,524 | 2,987 | 2,038 | 2,803 |
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment | 44.8 | 30.0 | 33.4 | 38.4 | 41.0 | 1.9 | 1.5 | 0.1 | 8,884 | 7,121 | 9,071 | 10,869 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 772 | 799 | 0 | 433 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25 | 38 | 380 | 437 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | 16 | 0 | 0 |
| Other Non-Current Assets | 15.6 | 1.9 | 2.3 | 2.3 | 2.3 | 2.3 | 0.2 | 0 | (31) | 1,665 | (536) | (329) |
| Total Non-Current Assets | 60.4 | 32.0 | 35.7 | 40.7 | 43.3 | 4.2 | 1.7 | 0.1 | 10,247 | 10,066 | 8,915 | 11,410 |
| Total Assets | 1,187.0 | 691.2 | 165.1 | 306.3 | 425.7 | 353.3 | 16.4 | 8.3 | 11,771 | 13,053 | 10,953 | 14,213 |
| Current Liabilities | ||||||||||||
| Account Payables | 8.1 | 6.6 | 22.9 | 5.3 | 4.0 | 3.4 | 1.3 | 0.5 | 367 | 332 | 181 | 303 |
| Short-Term Debt | 5.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105 | 201 | 807 | 64 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 5 | 6 | 6 |
| Other Current Liabilities | 37.5 | 30.8 | 0 | 0 | 0 | 0 | 0.6 | 0.0 | 570 | 378 | 853 | 1,329 |
| Total Current Liabilities | 50.6 | 42.3 | 51.1 | 28.1 | 28.7 | 11.0 | 2.4 | 0.7 | 1,049 | 916 | 1,847 | 1,702 |
| Non-Current Liabilities | ||||||||||||
| Long-Term Debt | 15.3 | 0 | 0 | 0 | 0 | 0 | 0 | 3.4 | 8,328 | 8,778 | 807 | 64 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 5 | 0 | 0 |
| Other Non-Current Liabilities | 148.9 | 0 | 0 | 0 | 0 | 0 | 0.0 | 9.1 | 146 | 170 | 359 | 500 |
| Total Non-Current Liabilities | 164.2 | 19.1 | 22.7 | 25.9 | 28.7 | 0 | 0.0 | 12.4 | 8,481 | 8,953 | 1,166 | 564 |
| Total Liabilities | 214.8 | 61.4 | 73.8 | 54.0 | 57.5 | 11.0 | 2.4 | 13.1 | 9,870 | 11,011 | 7,974 | 9,728 |
| Stockholders' Equity | ||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1 | 1 | 6 | 5 |
| Retained Earnings | (1,396.1) | (949.9) | (632.5) | (396.6) | (228.5) | (79.2) | (19.7) | (4.9) | (1,851) | (1,927) | 0 | 0 |
| Accumulated Other Comprehensive Income | 0 | 0.0 | 0 | (0.6) | (0.3) | (0.0) | 0 | (0.0) | 32 | 21 | (150) | (215) |
| Total Stockholders' Equity | 972.1 | 629.8 | 91.3 | 252.4 | 368.2 | 342.4 | 14.0 | (4.9) | 1,901 | 2,042 | 2,902 | 4,515 |
| Total Liabilities & Equity | 1,187.0 | 691.2 | 165.1 | 306.3 | 425.7 | 353.3 | 16.4 | 8.3 | 11,771 | 13,053 | 10,953 | 14,213 |
| Debt Metrics | ||||||||||||
| Total Debt | 20.3 | 24.0 | 27.4 | 30.5 | 32.6 | 0 | 0 | 3.4 | 8,433 | 8,979 | 1,614 | 128 |
| Net Debt | (873.1) | (411.5) | (94.2) | (141.7) | (168.2) | (300.9) | (14.6) | (4.7) | 8,068 | 7,203 | 1,143 | (565) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (446.2) | (317.4) | (235.9) | (168.1) | (149.3) | (59.4) | (14.9) | (4.8) | 76 | (1,240) |
| Depreciation & Amortization | 2.0 | (1.9) | 1.7 | 1.7 | 1.1 | 0.7 | 0.3 | 0.0 | 867 | 766 |
| Stock-Based Compensation | 45.9 | 45.9 | 20.0 | 15.2 | 17.5 | 6.6 | 0.0 | 0.0 | 0 | 0 |
| Change in Working Capital | (3.4) | (19.5) | 26.3 | (5.4) | 9.3 | 5.1 | 1.4 | 0.6 | (1,596) | 938 |
| Other Non-Cash Items | (1.5) | 0.6 | (0.2) | 3.0 | (0.7) | 0.5 | 1.3 | 0.0 | 584 | 136 |
| Operating Cash Flow | (403.2) | (292.4) | (188.2) | (153.6) | (119.6) | (46.5) | (11.8) | (4.2) | 585 | 676 |
| Investing Activities | ||||||||||
| Capital Expenditure | (1.9) | (2.4) | (0.7) | (3.1) | (3.6) | (1.2) | (1.6) | (0.1) | (224) | (326) |
| Acquisitions | 0 | 0 | 0 | 0.0 | 0.0 | 0 | 0 | 0 | (3,319) | 0 |
| Purchases of Investments | (180.5) | (317.4) | (44.3) | (121.2) | (236.7) | (44.5) | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 172.5 | 115.7 | 128.3 | 211.4 | 102.4 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (18.8) | 0.0 | 0 | (0.0) | (0.0) | 0 | 0 | 0 | 784 | (1,821) |
| Investing Cash Flow | (28.8) | (204.1) | 83.3 | 87.2 | (137.9) | (45.7) | (1.6) | (0.1) | (2,759) | (2,147) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 147.7 | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 36.8 | 2.0 | 0.5 | 0.6 | (0.4) | 0 | 5 | (1,299) | 2,742 |
| Financing Cash Flow | 890.3 | 809.9 | 54.3 | 37.4 | 157.8 | 380.7 | 20.0 | 12.4 | (1,299) | 2,742 |
| Cash Position | ||||||||||
| Net Change in Cash | 458.3 | 313.4 | (50.5) | (29.1) | (99.6) | 288.5 | 6.5 | 12.4 | (3,473) | 1,271 |
| Cash at Beginning | 437.4 | 123.9 | 174.5 | 203.5 | 303.2 | 14.6 | 8.1 | (4.3) | 3,838 | 505 |
| Cash at End | 895.7 | 437.4 | 123.9 | 174.5 | 203.5 | 303.2 | 14.6 | 8.1 | 365 | 1,776 |
| Free Cash Flow | (405.1) | (294.7) | (188.9) | (156.7) | (123.2) | (47.7) | (13.5) | (4.3) | 361 | 350 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 506 | 1,366 | 842 | 1,466 | 3 | 3 | 1,585 | 2,323 | 2,468 | 3,549 | 3,103 |
| Gross Profit | (2.0) | (2.2) | (2.5) | 0 | 0 | (0.7) | (0.3) | (0.0) | (2,426) | (915) | (1,186) | 321 | (1,142) | (265) | 622 | 1,142 | 1,274 | 1,696 | 1,090 |
| Operating Income | (468.2) | (343.9) | (242.2) | (171.0) | (150.0) | (58.6) | (13.8) | (4.8) | (412) | (640) | 64 | (318) | (318) | 714 | (236) | (11) | (834) | 709 | 605 |
| Net Income | (446.2) | (317.4) | (235.9) | (168.1) | (149.3) | (58.7) | (13.5) | (4.8) | 76 | (1,240) | 50 | (67) | (356) | 87 | (1,645) | (234) | (1,262) | 174 | 264 |
| EPS (Diluted) | -3.47 | -3.37 | -3.95 | -3.23 | -2.93 | -1.24 | -0.30 | -0.47 | 0.47 | -9.61 | 0.40 | -0.53 | -3.56 | 0.87 | -13.48 | -1.93 | -1.25 | 0.20 | 0.25 |
| Balance Sheet | |||||||||||||||||||
| Cash & Equivalents | 893.4 | 435.4 | 121.6 | 172.1 | 200.8 | 300.9 | 14.6 | 8.1 | 365 | 1,776 | 471 | 693 | |||||||
| Total Assets | 1,187.0 | 691.2 | 165.1 | 306.3 | 425.7 | 353.3 | 16.4 | 8.3 | 11,771 | 13,053 | 10,953 | 14,213 | |||||||
| Total Debt | 20.3 | 24.0 | 27.4 | 30.5 | 32.6 | 0 | 0 | 3.4 | 8,433 | 8,979 | 1,614 | 128 | |||||||
| Stockholders' Equity | 972.1 | 629.8 | 91.3 | 252.4 | 368.2 | 342.4 | 14.0 | (4.9) | 1,901 | 2,042 | 2,902 | 4,515 | |||||||
| Cash Flow | |||||||||||||||||||
| Operating Cash Flow | (403.2) | (292.4) | (188.2) | (153.6) | (119.6) | (46.5) | (11.8) | (4.2) | 585 | 676 | |||||||||
| Capital Expenditure | (1.9) | (2.4) | (0.7) | (3.1) | (3.6) | (1.2) | (1.6) | (0.1) | (224) | (326) | |||||||||
| Free Cash Flow | (405.1) | (294.7) | (188.9) | (156.7) | (123.2) | (47.7) | (13.5) | (4.3) | 361 | 350 | |||||||||